Cardiovascular involvement in Kawasaki disease

Indian Pediatrics

Volumn 42, Issue 9, 2005, Pages 918-922

  Narayanan, S Noel ^a   Ahamed, M Zulfikar ^a   Safia, M ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Coronary aneurysm; IV gammaglobulin; Pancarditis

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CARDITIS; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

AGE DISTRIBUTION; ARRHYTHMIA; ASPIRIN; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FEVER; HEMATOLOGIC TESTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INDIA; INFANT; LYMPHATIC DISEASES; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 25144443211     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pendse RN, Bhandari H, Vats AK, Bhabdari B. Kawasaki disease-Indian perspective. Indian J Pediatr 2001; 68: 775-777.
2. Narayanan SN, Krishna V, Sabarinathan K. Kawasaki disease. Indian Pediatr 1997; 34: 139-143.
3. Dajani AS, Bisno AL, Chung KJ, Durack DT, Gerber MA, Kaplan EL, et al. American Heart Association Committee on rheumatic fever, endocarditis and Kawasaki diseases. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990; 144: 1218-1219.
4. Genozo J, Miron D, Spiegel R, Fink D, Horowitz Y. Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis. Clin Pediatr 2003; 42: 263-267
5. Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis 1999; 28: 169-187
6. Shulman ST, de Inocencio J, Hirsch R. Kawasaki disease. Pediatr Clin N Am 1995; 42: 1205-1222.
7. Curtis N, Chan B, Levin M. Toxic shock syndrome toxin secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1994; 343: 299.
8. Rowley AH, Duffy CE, Shulman ST. Prevention of giant aneurysms in Kawasaki disease by intravenous gammaglobulin therapy. J Pediatr 1988; 113: 290-294.
9. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long term consequences of Kawasaki disease. Circulation 1996; 94: 1379-1385.
10. Fukushge J, Takashashi N, Ueda K, Hiju T, Igarashi H, Ohshima A. Longterm outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 1996; 17: 71-76.
11. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28: 253-257.
12. Adnans, Dajani A, Kathryn A, Taubert K, Masato T, Fred ZB, et al. Guidelines on long term management of patients with Kawasaki disease. Report from the Committee on Rheumatic fever, endocarditis and Kawasaki disease Council on Cardiovascular disease in the young. American Heart Association. Circulation 1994; 89: 916-922.
13. Chechia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki Disease. Pediatr 1997; 100: 695-699
14. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological surveys on Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995; 149: 779-783.
15. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. The fifth look. Arch Pediatr Adolesc Med 2002; 156: 162-165.
16. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005; 111: 38-43.